Glaukos (GKOS) Total Debt (2014 - 2021)

Glaukos (GKOS) posted quarterly Total Debt of $279.3 million for Q2 2021, little changed quarter-over-quarter from $279.0 million in Q1 2021.

Glaukos (GKOS) Total Debt (2014 - 2021) Analysis & Trends

Glaukos (GKOS) has reported Total Debt for 5 consecutive years, with $279.3 million the latest figure, recorded in Q2 2021.

In Q2 2021, Total Debt changed N/A year-over-year to $279.3 million; the TTM figure through Jun 2021 stood at $279.3 million (changed N/A YoY), while the FY2020 annual figure was $89.2 million, changed N/A from the prior year.
Total Debt was little changed at $279.3 million in Q2 2021 per GKOS's latest filing, from $279.0 million in the prior quarter.
Across five years, Total Debt topped out at $279.3 million in Q2 2021 and bottomed at $89.2 million in Q4 2020.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Total Debt (Qtr)
1	Abbott Laboratories	198.70 Bn	193.10 Bn	7.27 Bn	32.61 Bn
2	Stryker	125.85 Bn	122.37 Bn	4.50 Bn	14.94 Bn
3	Medtronic	118.44 Bn	109.22 Bn	6.41 Bn	27.96 Bn
4	Boston Scientific	72.64 Bn	72.10 Bn	3.85 Bn	12.62 Bn
5	Edwards Lifesciences	51.94 Bn	47.69 Bn	1.35 Bn	598.70 Mn
6	Dexcom	34.48 Bn	32.53 Bn	830.00 Mn	-
7	GE HealthCare Technologies	33.60 Bn	31.49 Bn	2.18 Bn	10.10 Bn
8	Koninklijke Philips	26.30 Bn	22.98 Bn	4.55 Bn	8.68 Bn
9	Steris	23.00 Bn	22.52 Bn	684.20 Mn	1.89 Bn
10	Glaukos	10.91 Bn	10.80 Bn	151.59 Mn	-

Download Data